Draft monograph: CJC-1295 — disposition

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

§3.3Resulting amendments

1. Effect estimates are given without naming the comparator — arising from DRAFT-CJC-1295-MON/004. The comparator is now stated in every outcome row, and estimates against different comparators are reported in separate tables with the comparator named in the table caption.
2. The population to which the headline estimate applies is not stated with the estimate — arising from DRAFT-CJC-1295-MON/003. Every headline estimate now carries a one-line statement of the population in which it was observed, and the full eligibility criteria are reported in the included-studies table rather than only in the source.
3. Regulatory status is stated without naming the jurisdiction — arising from DRAFT-CJC-1295-MON/012. Every regulatory status statement now names the authority, states the date on which the status was verified, and is recorded per jurisdiction rather than as a single global assertion.
4. Trials are described as terminated where they completed as planned — arising from DRAFT-CJC-1295-MON/011. Trial status now uses a fixed vocabulary defined in the glossary, and where the reason for stopping is not evidenced by a document the Institute holds, the status is recorded as stopped with the reason not established rather than assigned.
5. What happens when the compound is stopped is not addressed — arising from DRAFT-CJC-1295-MON/001. Discontinuation trajectory is now an assessed outcome in every monograph where a contributing trial measured it, and a recorded evidence gap in every monograph where none did, so that its absence is visible rather than silent.
6. The compound is supplied under names the monograph does not list — arising from DRAFT-CJC-1295-MON/007. The synonym list is extended to include every name the Institute can evidence from a document it holds, each recorded with its source. Names asserted without a supporting document are not added, and the distinction is stated at the head of the list.
7. Quantitative claims are reproduced without the method that produced them — arising from DRAFT-CJC-1295-MON/010. Every quantitative claim now carries the determination that produced it at the point of use, and figures obtained by non-comparable methods are no longer presented in the same row or sentence.
8. The recorded evidence gaps omit outcomes a reader would consider material — arising from DRAFT-CJC-1295-MON/009. The evidence-gap section is now derived from the anchor and decision-relevant outcomes for the indication, and any such outcome measured by no contributing trial is recorded as not measured rather than omitted.
9. Storage and reconstitution guidance is given without stating what it rests on — arising from DRAFT-CJC-1295-MON/008. In-use periods now appear only where supported by a cited stability determination on a stated presentation, and elsewhere the monograph records that no in-use stability evidence was identified for this presentation.
10. The monograph does not tell a reader that a stated mass may be substantially counter-ion and water — arising from DRAFT-CJC-1295-MON/005. The monograph now states, at the point where vial contents are first mentioned, that a mass figure is uninterpretable unless it states whether it is peptide content or total solids, and cross-references the content standard in the analytical series.
11. References should carry a persistent identifier for every cited source — arising from DRAFT-CJC-1295-MON/013. Every reference without a persistent identifier now carries an explicit statement that the identifier is not held by the Institute, so that its absence is a recorded fact rather than an apparent oversight.
12. Every contributing trial shares one sponsor and the monograph does not say so — arising from DRAFT-CJC-1295-MON/006. Sponsor concentration is now stated with the certainty rating, and the monograph records how many independent sponsors contributed evidence to each assessed outcome.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.